Shanghai Institute of Pharmaceutical Industry;China State Institute of Pharmaceutical Industry
发明人:
申请号：
EP17845414.6
公开号：
EP3508478A1
申请日:
2017.08.30
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention discloses a salt derivative of 1-(3-methanesulfonamidobenzyl)-6-methoxy-7-benzyloxy-1,2,3,4-tetrahydroisoquinoline shown in formula I. The salt derivative has a solubility in water of not less than 3.0 nmol/mL or 1.8 mg/mL:The salt derivative has a solubility in water of not less than 3.0 nmol/mL or 1.8 mg/mL
